Two drugs to treat “off” times in PD could be the first MJFF-funded therapies to come to market if approved by the FDA. Also read about progress in the Foundation’s online study Fox Insight, Governor Rendell’s (D-PA) diagnosis, advances in dementia research and tried-and-true tips for fundraising. Plus
